000			01576 a2200409 4500
005			20250514014741.0
264		0	_c20020118
008			200201s 0 0 eng d
022			_a0269-9370
024	7		_a10.1097/00002030-200111090-00017 _2doi
040			_aNLM _beng _cNLM
100	1		_aWensing, A M
245	0	0	_aReplacing ritonavir by nelfinavir or nelfinavir/saquinavir as part of highly active antiretroviral therapy leads to an improvement of triglyceride levels. _h[electronic resource]
260			_bAIDS (London, England) _cNov 2001
300			_a2191-3 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAnti-HIV Agents _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV Protease Inhibitors _xtherapeutic use
650	0	4	_aHIV-1 _xisolation & purification
650	0	4	_aHumans
650	0	4	_aNelfinavir _xtherapeutic use
650	0	4	_aReverse Transcriptase Inhibitors _xtherapeutic use
650	0	4	_aRitonavir _xtherapeutic use
650	0	4	_aSaquinavir _xtherapeutic use
650	0	4	_aTreatment Outcome
650	0	4	_aTriglycerides _xblood
700	1		_aReedijk, M
700	1		_aRichter, C
700	1		_aBoucher, C A
700	1		_aBorleffs, J C
773	0		_tAIDS (London, England) _gvol. 15 _gno. 16 _gp. 2191-3
856	4	0	_uhttps://doi.org/10.1097/00002030-200111090-00017 _zAvailable from publisher's website
999			_c11601757 _d11601757